Business Context and Reporting Period
This Form 8-K reports on events occurring on May 23, 2024, regarding Nephros, Inc. (Nasdaq: NEPH). The filing details the outcomes of the Company's 2024 Annual Meeting of Stockholders, including the election of directors, ratification of auditors, and approval of equity and compensation plans.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
At the Annual Meeting, stockholders voted on four key matters. The results were as follows:
- Election of Directors: Arthur H. Amron and Oliver Spandow were elected to three-year terms expiring in 2027.
- Arthur H. Amron: 6,860,037 For; 41,693 Withheld.
- Oliver Spandow: 6,690,864 For; 210,866 Withheld.
- Ratification of Auditors: Baker Tilly US, LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
- 8,545,420 For; 21,330 Against; 3,188 Abstain.
- 2024 Equity Incentive Plan: Stockholders approved the Nephros, Inc. 2024 Equity Incentive Plan.
- 6,498,286 For; 383,807 Against; 19,637 Abstain.
- Executive Compensation: Stockholders approved the compensation of named executive officers on an advisory (non-binding) basis.
- 6,832,340 For; 62,907 Against; 6,483 Abstain.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, risks, contingencies, or unusual items. It strictly reports the procedural outcomes of the Annual Meeting.
Investor Verification Checklist
- Verify the terms of the newly approved 2024 Equity Incentive Plan (Exhibit 10.1) to understand potential dilution and grant limits.
- Confirm the tenure of the newly elected directors, Arthur H. Amron and Oliver Spandow, which expires in 2027.
- Note the significant number of Broker Non-Votes (1,668,208) on director elections and the equity plan, indicating shares held by brokers that were not voted on these specific matters.
- Review the definitive proxy statement filed on April 12, 2024, for detailed descriptions of the 2024 Plan material terms referenced in this filing.